BIOMAT Database Logo BIOMAT Database Logo

Celecoxib versus indomethacin in the prevention of heterotopic ossification after total hip arthroplasty. 2004

Carlo L Romanò, and Dario Duci, and Delia Romanò, and Mario Mazza, and Enzo Meani
Department of Othopaedic Surger C.O.S., Istituto Orhtopedico Gaetano Pini, 9-20121 Milano, Italia.

A cyclo-oxygenase (COX)-1 and COX-2 inhibitor (indomethacin) and a selective COX-2 inhibitor (celecoxib) were compared in the prevention of heterotopic ossification after total hip arthroplasty. In 250 patients receiving indomethacin and in 150 patients receiving celecoxib for 20 days after surgery, an overall incidence of heterotopic ossification of 17.5% and 14.3% was seen, respectively (difference not statistically significant: P > .05). No grade III or IV ossifications were seen in either group. Twenty-one patients in the indomethacin group (8.4%) and 3 patients in the celecoxib group (2.0%) required treatment discontinuation, because of side effects (P < .05). Celecoxib, a selective COX-2 inhibitor, shows the same efficacy as indomethacin in the prevention of heterotopic ossification after hip prosthesis with significantly fewer side effects.

UI MeSH Term Description Entries
D007213 Indomethacin A non-steroidal anti-inflammatory agent (NSAID) that inhibits CYCLOOXYGENASE, which is necessary for the formation of PROSTAGLANDINS and other AUTACOIDS. It also inhibits the motility of POLYMORPHONUCLEAR LEUKOCYTES. Amuno,Indocid,Indocin,Indomet 140,Indometacin,Indomethacin Hydrochloride,Metindol,Osmosin
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009999 Ossification, Heterotopic The development of bony substance in normally soft structures. Ossification, Pathologic,Ectopic Ossification,Heterotopic Ossification,Ossification, Ectopic,Ossification, Pathological,Pathologic Ossification,Pathological Ossification
D011446 Prospective Studies Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group. Prospective Study,Studies, Prospective,Study, Prospective
D011720 Pyrazoles Azoles of two nitrogens at the 1,2 positions, next to each other, in contrast with IMIDAZOLES in which they are at the 1,3 positions.
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000068579 Celecoxib A pyrazole derivative and selective CYCLOOXYGENASE 2 INHIBITOR that is used to treat symptoms associated with RHEUMATOID ARTHRITIS; OSTEOARTHRITIS and JUVENILE ARTHRITIS, as well as the management of ACUTE PAIN. 4-(5-(4-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)benzenesulfonamide,Celebrex,SC 58635,SC-58635,SC58635
D000894 Anti-Inflammatory Agents, Non-Steroidal Anti-inflammatory agents that are non-steroidal in nature. In addition to anti-inflammatory actions, they have analgesic, antipyretic, and platelet-inhibitory actions. They act by blocking the synthesis of prostaglandins by inhibiting cyclooxygenase, which converts arachidonic acid to cyclic endoperoxides, precursors of prostaglandins. Inhibition of prostaglandin synthesis accounts for their analgesic, antipyretic, and platelet-inhibitory actions; other mechanisms may contribute to their anti-inflammatory effects. Analgesics, Anti-Inflammatory,Aspirin-Like Agent,Aspirin-Like Agents,NSAID,Non-Steroidal Anti-Inflammatory Agent,Non-Steroidal Anti-Inflammatory Agents,Nonsteroidal Anti-Inflammatory Agent,Anti Inflammatory Agents, Nonsteroidal,Antiinflammatory Agents, Non Steroidal,Antiinflammatory Agents, Nonsteroidal,NSAIDs,Nonsteroidal Anti-Inflammatory Agents,Agent, Aspirin-Like,Agent, Non-Steroidal Anti-Inflammatory,Agent, Nonsteroidal Anti-Inflammatory,Anti-Inflammatory Agent, Non-Steroidal,Anti-Inflammatory Agent, Nonsteroidal,Anti-Inflammatory Analgesics,Aspirin Like Agent,Aspirin Like Agents,Non Steroidal Anti Inflammatory Agent,Non Steroidal Anti Inflammatory Agents,Nonsteroidal Anti Inflammatory Agent,Nonsteroidal Anti Inflammatory Agents,Nonsteroidal Antiinflammatory Agents

Related Publications

Carlo L Romanò, and Dario Duci, and Delia Romanò, and Mario Mazza, and Enzo Meani
Indomethacin versus meloxicam for prevention of heterotopic ossification after total hip arthroplasty.
April 2003, Archives of orthopaedic and trauma surgery,
Carlo L Romanò, and Dario Duci, and Delia Romanò, and Mario Mazza, and Enzo Meani
Indomethacin for prevention of heterotopic ossification after total hip arthroplasty.
March 1992, The Journal of arthroplasty,
Carlo L Romanò, and Dario Duci, and Delia Romanò, and Mario Mazza, and Enzo Meani
Combined radiotherapy and indomethacin for the prevention of heterotopic ossification after total hip arthroplasty.
August 2009, Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al],
Carlo L Romanò, and Dario Duci, and Delia Romanò, and Mario Mazza, and Enzo Meani
Indomethacin versus radiation therapy for heterotopic ossification after hip arthroplasty.
December 2001, Orthopedics,
Carlo L Romanò, and Dario Duci, and Delia Romanò, and Mario Mazza, and Enzo Meani
Heterotopic ossification after total hip arthroplasty.
November 2011, American journal of orthopedics (Belle Mead, N.J.),
Carlo L Romanò, and Dario Duci, and Delia Romanò, and Mario Mazza, and Enzo Meani
Heterotopic ossification after total hip arthroplasty.
January 2001, International orthopaedics,
Carlo L Romanò, and Dario Duci, and Delia Romanò, and Mario Mazza, and Enzo Meani
Heterotopic ossification after total hip arthroplasty.
April 1994, Canadian journal of surgery. Journal canadien de chirurgie,
Carlo L Romanò, and Dario Duci, and Delia Romanò, and Mario Mazza, and Enzo Meani
Heterotopic ossification after total hip arthroplasty: risk factors and prevention.
April 1998, Revue du rhumatisme (English ed.),
Carlo L Romanò, and Dario Duci, and Delia Romanò, and Mario Mazza, and Enzo Meani
Radiation therapy in the prevention of heterotopic ossification after total hip arthroplasty.
January 1982, The Hip,
Carlo L Romanò, and Dario Duci, and Delia Romanò, and Mario Mazza, and Enzo Meani
Cost of radiotherapy versus NSAID administration for prevention of heterotopic ossification after total hip arthroplasty.
August 2008, International journal of radiation oncology, biology, physics,
Copied contents to your clipboard!